Identification and synthesis of the epitope for a human monoclonal antibody which can neutralize human T-cell leukemia/lymphotropic virus type I

S. Ralston, P. Hoeprich, R. Akita

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

A monoclonal antibody (mAb), designated 0.5α, derived from a patient with adult T-cell leukemia was found previously to neutralize the human T-cell leukemia/lymphotropic type I (HTLV-I) virus in in vitro assays and bind to the major envelope glycoprotein (gp46) of HTLV-I (Matsushita, S., Guroff, M.R., Trepel, J., Crossman, J., Mitsuya, H., and Broder, S. (1986) Proc. Natl. Acad. Sci. U.S.A. 83, 2671-2676). We have designed experiments to determine the epitope for this mAb. Using simultaneous multiple peptide synthesis, we synthesized 481 overlapping octapeptides which corresponded to the sequence of gp46. We mapped the epitope for mAb 0.5α to lie between residues 186 and 195 of gp46. This result was confirmed by independently synthesizing a peptide containing this epitope which bound specifically to mAb 0.5α with an approximate K(a) = 4 x 107 M-1. In addition, the peptide inhibited mAb 0.5α binding to gp46 derived from T-cells infected with HTLV-I. This epitope containing peptide may facilitate understanding HTLV-I infection of T-cells.

Original languageEnglish (US)
Pages (from-to)16343-16346
Number of pages4
JournalJournal of Biological Chemistry
Volume264
Issue number28
StatePublished - 1989
Externally publishedYes

Fingerprint

Human T-lymphotropic virus 1
T-cells
Viruses
Epitopes
Monoclonal Antibodies
Peptides
HTLV-I Infections
Deltaretrovirus
T-Lymphocytes
T-Cell Leukemia
Adult T Cell Leukemia Lymphoma
Assays
Glycoproteins
Experiments

ASJC Scopus subject areas

  • Biochemistry

Cite this

Identification and synthesis of the epitope for a human monoclonal antibody which can neutralize human T-cell leukemia/lymphotropic virus type I. / Ralston, S.; Hoeprich, P.; Akita, R.

In: Journal of Biological Chemistry, Vol. 264, No. 28, 1989, p. 16343-16346.

Research output: Contribution to journalArticle

@article{e8152e330fee4421a5dbac4c325f755e,
title = "Identification and synthesis of the epitope for a human monoclonal antibody which can neutralize human T-cell leukemia/lymphotropic virus type I",
abstract = "A monoclonal antibody (mAb), designated 0.5α, derived from a patient with adult T-cell leukemia was found previously to neutralize the human T-cell leukemia/lymphotropic type I (HTLV-I) virus in in vitro assays and bind to the major envelope glycoprotein (gp46) of HTLV-I (Matsushita, S., Guroff, M.R., Trepel, J., Crossman, J., Mitsuya, H., and Broder, S. (1986) Proc. Natl. Acad. Sci. U.S.A. 83, 2671-2676). We have designed experiments to determine the epitope for this mAb. Using simultaneous multiple peptide synthesis, we synthesized 481 overlapping octapeptides which corresponded to the sequence of gp46. We mapped the epitope for mAb 0.5α to lie between residues 186 and 195 of gp46. This result was confirmed by independently synthesizing a peptide containing this epitope which bound specifically to mAb 0.5α with an approximate K(a) = 4 x 107 M-1. In addition, the peptide inhibited mAb 0.5α binding to gp46 derived from T-cells infected with HTLV-I. This epitope containing peptide may facilitate understanding HTLV-I infection of T-cells.",
author = "S. Ralston and P. Hoeprich and R. Akita",
year = "1989",
language = "English (US)",
volume = "264",
pages = "16343--16346",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "28",

}

TY - JOUR

T1 - Identification and synthesis of the epitope for a human monoclonal antibody which can neutralize human T-cell leukemia/lymphotropic virus type I

AU - Ralston, S.

AU - Hoeprich, P.

AU - Akita, R.

PY - 1989

Y1 - 1989

N2 - A monoclonal antibody (mAb), designated 0.5α, derived from a patient with adult T-cell leukemia was found previously to neutralize the human T-cell leukemia/lymphotropic type I (HTLV-I) virus in in vitro assays and bind to the major envelope glycoprotein (gp46) of HTLV-I (Matsushita, S., Guroff, M.R., Trepel, J., Crossman, J., Mitsuya, H., and Broder, S. (1986) Proc. Natl. Acad. Sci. U.S.A. 83, 2671-2676). We have designed experiments to determine the epitope for this mAb. Using simultaneous multiple peptide synthesis, we synthesized 481 overlapping octapeptides which corresponded to the sequence of gp46. We mapped the epitope for mAb 0.5α to lie between residues 186 and 195 of gp46. This result was confirmed by independently synthesizing a peptide containing this epitope which bound specifically to mAb 0.5α with an approximate K(a) = 4 x 107 M-1. In addition, the peptide inhibited mAb 0.5α binding to gp46 derived from T-cells infected with HTLV-I. This epitope containing peptide may facilitate understanding HTLV-I infection of T-cells.

AB - A monoclonal antibody (mAb), designated 0.5α, derived from a patient with adult T-cell leukemia was found previously to neutralize the human T-cell leukemia/lymphotropic type I (HTLV-I) virus in in vitro assays and bind to the major envelope glycoprotein (gp46) of HTLV-I (Matsushita, S., Guroff, M.R., Trepel, J., Crossman, J., Mitsuya, H., and Broder, S. (1986) Proc. Natl. Acad. Sci. U.S.A. 83, 2671-2676). We have designed experiments to determine the epitope for this mAb. Using simultaneous multiple peptide synthesis, we synthesized 481 overlapping octapeptides which corresponded to the sequence of gp46. We mapped the epitope for mAb 0.5α to lie between residues 186 and 195 of gp46. This result was confirmed by independently synthesizing a peptide containing this epitope which bound specifically to mAb 0.5α with an approximate K(a) = 4 x 107 M-1. In addition, the peptide inhibited mAb 0.5α binding to gp46 derived from T-cells infected with HTLV-I. This epitope containing peptide may facilitate understanding HTLV-I infection of T-cells.

UR - http://www.scopus.com/inward/record.url?scp=0024443050&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024443050&partnerID=8YFLogxK

M3 - Article

C2 - 2476442

AN - SCOPUS:0024443050

VL - 264

SP - 16343

EP - 16346

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 28

ER -